ASND (Ascendis Pharma AS) 3-Year Revenue Growth Rate : 245.10% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma AS 3-Year Revenue Growth Rate?

Ascendis Pharma AS's Revenue per Share for the three months ended in Dec. 2024 was $3.05.

During the past 12 months, Ascendis Pharma AS's average Revenue per Share Growth Rate was 27.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 245.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 117.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ascendis Pharma AS was 245.10% per year. The lowest was -62.40% per year. And the median was 6.45% per year.

Competitive Comparison of Ascendis Pharma AS's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Ascendis Pharma AS's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Ascendis Pharma AS 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ascendis Pharma AS (NAS:ASND) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ascendis Pharma AS 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.